• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095

Introduction to N-2-(4-acetylphenyl)ethylacetamide and Its Significance in Modern Chemical Research

N-2-(4-acetylphenyl)ethylacetamide, a compound with the CAS number 23279-64-3, represents a fascinating subject of study in the realm of chemical biology and pharmaceutical development. This compound, characterized by its intricate molecular structure, has garnered attention due to its potential applications in various therapeutic areas. The presence of both acetyl and amide functional groups in its molecular framework suggests a high degree of reactivity and versatility, making it a valuable candidate for further exploration.

The molecular formula of N-2-(4-acetylphenyl)ethylacetamide can be expressed as C₁₂H₁₃NO₂, which highlights its composition and the types of atoms it contains. This specific arrangement of carbon, hydrogen, nitrogen, and oxygen atoms contributes to its unique chemical properties. The compound's structure is reminiscent of many biologically active molecules, which often feature aromatic rings and amide linkages. These features are not only central to its chemical behavior but also play a crucial role in its potential biological activity.

In recent years, there has been a surge in research focusing on the development of novel compounds that can modulate biological pathways. N-2-(4-acetylphenyl)ethylacetamide fits well within this context, as its structural motifs are commonly found in drugs that target neurological disorders, inflammation, and other complex diseases. The acetylphenyl moiety, in particular, has been studied for its ability to interact with various biological targets, including enzymes and receptors.

One of the most intriguing aspects of N-2-(4-acetylphenyl)ethylacetamide is its potential role as a scaffold for drug discovery. By modifying its structure, researchers can explore a wide range of pharmacological activities. For instance, the introduction of additional functional groups or the alteration of the aromatic ring can lead to compounds with enhanced binding affinity or selectivity. This flexibility makes it an attractive candidate for medicinal chemists seeking to develop new therapeutic agents.

The synthesis of N-2-(4-acetylphenyl)ethylacetamide involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include the condensation of 4-acetylbenzaldehyde with ethyl acetoacetate in the presence of a base catalyst. This reaction typically proceeds via an aldol condensation followed by cyclization and subsequent hydrolysis steps. The choice of catalyst and reaction conditions can significantly influence the efficiency and scalability of the synthesis.

Recent advancements in synthetic chemistry have enabled more efficient and sustainable methods for producing complex molecules like N-2-(4-acetylphenyl)ethylacetamide. Techniques such as flow chemistry and microwave-assisted synthesis have reduced reaction times and improved yields while minimizing waste. These innovations are particularly important in pharmaceutical research, where cost-effective and environmentally friendly synthetic routes are highly valued.

The pharmacological properties of N-2-(4-acetylphenyl)ethylacetamide have been the subject of several preliminary studies. Initial investigations suggest that it may exhibit anti-inflammatory effects by modulating key signaling pathways involved in immune responses. The amide group is known to interact with various enzymes, including those involved in prostaglandin synthesis and leukotriene production. By inhibiting these pathways, the compound could potentially reduce inflammation and alleviate symptoms associated with chronic inflammatory diseases.

In addition to its anti-inflammatory potential, N-2-(4-acetylphenyl)ethylacetamide has shown promise in preclinical models as a potential treatment for neurological disorders. The acetylphenyl moiety is known to cross the blood-brain barrier, allowing it to reach central nervous system targets. Studies have indicated that it may interact with neurotransmitter receptors and ion channels, potentially leading to therapeutic effects in conditions such as epilepsy or neurodegenerative diseases.

The development of new drugs often involves rigorous testing to evaluate their safety and efficacy. N-2-(4-acetylphenyl)ethylacetamide is no exception, with researchers conducting extensive toxicity studies to assess its potential side effects. These studies include acute toxicity tests, chronic exposure assessments, and evaluations of organ-specific effects. By thoroughly characterizing its safety profile, scientists can better understand how it behaves within biological systems and identify any potential risks associated with its use.

The regulatory landscape for new drug development also plays a critical role in determining how quickly compounds like N-2-(4-acetylphenyl)ethylacetamide can move from laboratory research to clinical use. Regulatory agencies require comprehensive data on a drug's chemical properties, pharmacological activity, safety profile, and manufacturing processes before approving it for human consumption. This stringent evaluation ensures that only safe and effective medications reach patients.

Collaboration between academic researchers, pharmaceutical companies, and regulatory agencies is essential for advancing the development of novel compounds like N-2-(4-acetylphenyl)ethylacetamide. Such partnerships facilitate the sharing of knowledge, resources, and expertise needed to navigate the complex process of drug discovery and development. By working together, stakeholders can accelerate the translation of laboratory findings into tangible therapeutic benefits for patients worldwide.

The future prospects for N-2-(4-acetylphenyl)ethylacetamide are promising given its unique structural features and potential biological activities. Ongoing research aims to further elucidate its mechanism of action and explore new applications in medicine. As our understanding of biological systems continues to grow, compounds like this one will likely play an increasingly important role in addressing some of humanity's most pressing health challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)